LYEL
Lyell Immunopharma, Inc.
$14.04
-0.01 (-0.07%)
At close · Jul 6
Market Cap
$327.61M
Shares
23,334,087
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $0 | 10-K, filed 2023-02-28 |
| 2021-12-31 | $0 | 10-K, filed 2023-02-28 |
| 2020-12-31 | $11,806,000 | 10-K, filed 2023-02-28 |
| 2019-12-31 | $185,000 | 10-K, filed 2022-03-29 |